Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2018-05-16 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BOURGOIN-JALLIEU (38300), Isere
PHARMACIE DE LA GRIVE : revenue, balance sheet and financial ratios
PHARMACIE DE LA GRIVE is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BOURGOIN-JALLIEU (38300),
this company of category PME
shows in 2023 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA GRIVE (SIREN 839658978)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
1 898 327 €
1 732 089 €
1 555 036 €
N/C
N/C
Net income
121 998 €
110 878 €
55 694 €
37 777 €
43 143 €
45 189 €
11 171 €
EBITDA
N/C
N/C
74 543 €
77 512 €
85 607 €
N/C
N/C
Net margin
N/C
N/C
2.9%
2.2%
2.8%
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA GRIVE generates positive net income of 122 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 11 k€ -> 122 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
121 998 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 161%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
161.331%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
31.403%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA GRIVE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
2350.832
1342.533
869.041
631.16
429.51
254.795
161.331
Financial autonomy
3.597
5.858
9.219
11.633
15.779
22.834
31.403
Repayment capacity
None
None
19.917
20.974
14.527
None
None
Cash flow / Revenue
None%
None%
3.913%
3.08%
3.628%
None%
None%
Sector positioning
Debt ratio
161.332025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of PHARMACIE DE LA GRIVE (161.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
31.4%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE DE LA GRIVE (31.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
14.53 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Watch
In 2023, the repayment capacity of PHARMACIE DE LA GRIVE (14.53) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 139.43. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
139.43
Liquidity indicators evolution PHARMACIE DE LA GRIVE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
188.217
217.003
268.831
203.265
173.334
148.811
139.43
Interest coverage
None
None
11.984
9.468
8.743
None
None
Sector positioning
Liquidity ratio
139.432025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average-13 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA GRIVE (139.43) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
8.74x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE DE LA GRIVE (8.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 32 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 601 days. Excellent situation: suppliers finance 569 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
32 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
601 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA GRIVE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
187 320 €
205 720 €
232 355 €
0 €
0 €
Inventory turnover (days)
0
0
48
51
43
0
0
Customer payment term (days)
9
13
1
1
1
26
32
Supplier payment term (days)
538
824
28
36
39
613
601
Positioning of PHARMACIE DE LA GRIVE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA GRIVE is estimated at
1 937 952 €
(range 1 315 103€ - 3 040 914€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1315k€1937k€3040k€
1 937 952 €Range: 1 315 103€ - 3 040 914€
NAF 5 année 2025
Valuation method used
Net Income Multiple
121 998 €
×
15.9x
=1 937 953 €
Range: 1 315 104€ - 3 040 915€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA GRIVE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA GRIVE
What is the revenue of PHARMACIE DE LA GRIVE ?
The revenue of PHARMACIE DE LA GRIVE in 2023 is 1.9 M€.
Is PHARMACIE DE LA GRIVE profitable?
Yes, PHARMACIE DE LA GRIVE generated a net profit of 122 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA GRIVE ?
The headquarters of PHARMACIE DE LA GRIVE is located in BOURGOIN-JALLIEU (38300), in the department Isere.
Where to find the tax return of PHARMACIE DE LA GRIVE ?
The tax return of PHARMACIE DE LA GRIVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA GRIVE operate?
PHARMACIE DE LA GRIVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart